Literature DB >> 16275264

Circulating antibodies to human spermatozoa in patients with ulcerative colitis.

Dimitrina Dimitrova1, Svetoslav Kalaydjiev, Antonya Mendizova, Evgeniya Piryova, Lyudmil Nakov.   

Abstract

The existence of enhanced humoral immunity against sperm antigens in patients with ulcerative colitis might be a result of the increased intestinal permeability, and may be associated with immunization against antigens of the common intestinal flora possessing common antigenicity with spermatozoa. The result of these two processes is statistically significant increased antisperm antibody (ASA) incidence in patients with ulcerative colitis compared to the healthy blood donors of proven fertility without clinical symptoms of inflammatory bowel diseases at the same age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275264     DOI: 10.1016/j.fertnstert.2005.05.041

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Sexual dysfunction and male infertility.

Authors:  Francesco Lotti; Mario Maggi
Journal:  Nat Rev Urol       Date:  2018-03-13       Impact factor: 14.432

Review 2.  Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review.

Authors:  Stefano Palomba; Giuliana Sereni; Angela Falbo; Marina Beltrami; Silvia Lombardini; Maria Chiara Boni; Giovanni Fornaciari; Romano Sassatelli; Giovanni Battista La Sala
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 3.  Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone.

Authors:  Kadri Haller-Kikkatalo; Andres Salumets; Raivo Uibo
Journal:  Clin Dev Immunol       Date:  2011-10-05

4.  Cyanidin-3-O-Glucoside Supplement Improves Sperm Quality and Spermatogenesis in a Mice Model of Ulcerative Colitis.

Authors:  Yuhang Xiao; Baojun Xu; Matteo Bordiga; Haiwei Li; Fabiano Travaglia; Shun Bai; Jiali Chen; Weibin Bai
Journal:  Nutrients       Date:  2022-02-25       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.